Nuvation Bio Inc. — Director's Dealing 2023

Mar 3, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nuvation Bio Inc. (NUVB)
CIK: 0001811063
Period of Report: 2023-02-28

Reporting Person: Hanley David C. (Chief Technical Operations)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-28	Stock Option (Right to Buy)	$1.94	A	500000	Acquired	2033-02-27	Class A Common Stock (500000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	6000	Direct

Footnotes

F1: Includes 3,000 shares acquired on May 19, 2022 and 3,000 shares acquired on November 18, 2022 under the Issuer's 2021 Employee Stock Purchase Plan.

F2: Option vests as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.